Ying Huang's post-Legend life takes shape at K2, with $250M goal to license Asia assets
Ying Huang's post-Legend life takes shape at K2, with $250M goal to license Asia assets
K2 Bio
Private
New cell therapy licensing company founded by Ying Huang (former Legend Biotech CMO). Focused on licensing Asian cell therapy assets into Western markets with a $250M target raise.
Company Info
Sector:Cell Therapy / Oncology
Headquarters:New Jersey, USA
Founded:2026
Website:www.k2-biolabs.com/
Funding Round:Seed / Series A targeting $250M
Upcoming Milestones & Key Dates
2026 H2
Financing
Seed/Series A close expected ($250M target)
Recent News
Leadership Team
Ying Huang
Founder & Chief Executive Officer